Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation
- 30 May 2008
- journal article
- review article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 30 (3) , 172-179
- https://doi.org/10.1016/j.jaut.2007.12.002
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Hunt for pluripotent stem cell – Regenerative medicine search for almighty cellJournal of Autoimmunity, 2008
- Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesBlood, 2007
- The unexpected effect of cyclosporin A on CD56+CD16− and CD56+CD16+ natural killer cell subpopulationsBlood, 2007
- Graft-Versus-Host Disease: A Surge of DevelopmentsPLoS Medicine, 2007
- Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.Blood, 2007
- Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donorsBlood, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsThe Journal of Experimental Medicine, 2006
- Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicityBlood, 2005
- Tumor antigen immunization of sibling stem cell transplant donors in multiple myelomaBone Marrow Transplantation, 2005
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986